Article 16 Jan 2025 FDA Finalizes Its SIUU Guidance: An Analysis Of The Key Changes From The 2023 Draft Guidance United States Healthcare
Article 17 Dec 2024 FDA Issues New Draft Guidance For Expedited Program For Serious Conditions — Accelerated Approval Of Drugs And Biologics United States Healthcare
Article 15 Jul 2024 FDA Issues Revised Draft Guidance On Addressing Misinformation About Medical Devices And Prescription Drugs United States Healthcare
Article 03 Jul 2024 Chevron Overturned: What Does It Mean For Life Sciences Companies? United States Healthcare